Association between genotype and drug resistance profiles of Mycobacterium tuberculosis strains circulating in China in a national drug resistance survey

被引:26
|
作者
Zhou, Yang [1 ]
van den Hof, Susan [2 ,3 ]
Wang, Shengfen [1 ]
Pang, Yu [1 ]
Zhao, Bing [1 ]
Xia, Hui [1 ]
Anthony, Richard [4 ]
Ou, Xichao [1 ]
Li, Qiang [1 ]
Zheng, Yang [1 ]
Song, Yuanyuan [1 ]
Zhao, Yanlin [1 ]
van Soolingen, Dick [4 ]
机构
[1] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China
[2] KNCV TB Fdn, The Hague, Netherlands
[3] Amsterdam Med Ctr, Dept Global Hlth, Pietersbergweg 17, Amsterdam, Netherlands
[4] Natl Inst Publ Hlth & Environm, Bilthoven, Netherlands
来源
PLOS ONE | 2017年 / 12卷 / 03期
关键词
LARGE SEQUENCE POLYMORPHISMS; GENETIC DIVERSITY; BEIJING GENOTYPE; EVOLUTION; ORIGIN; CLONE; SUBLINEAGES; PULMONARY; RIFAMPIN; INSIGHTS;
D O I
10.1371/journal.pone.0174197
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
We describe the population structure of a representative collection of 3,133 Mycobacterium tuberculosis isolates, collected within the framework of a national resistance survey from 2007 in China. Genotyping data indicate that the epidemic strains in China can be divided into seven major complexes, of which 92% belonged to the East Asian (mainly Beijing strains) or the Euro-American lineage. The epidemic Beijing strains in China are closely related to the Beijing B0/W148 strain earlier described in Russia and a large cluster of these strains has spread national wide. The density of Beijing strains is high in the whole of China (average 70%), but the highest prevalence was found North of the Yellow river. The Euro-American lineage consists of three sublineages (sublineage_1, 2, and 3) and is more prevalent in the South. Beijing lineage showed the highest cluster rate of 48% and a significantly higher level of resistance to rifampicin (14%, p < 0.001), ethambutol (9%, p = 0.001), and ofloxacin (5%, p = 0.011). Within the Euro-American Lineage, sublineage_3 revealed the highest cluster rate (28%) and presented a significantly elevated level of resistance to streptomycin (44%, p < 0.001). Our findings suggest that standardised treatment in this region may have contributed to the successful spread of certain strains: sublineage_3 in the Euro-American lineage may have thrived when streptomycin was used without rifampicin for treatment, while later under DOTS based treatment, in which rifampicin plays a key role, Beijing lineage appears to be spreading.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] First national survey of Mycobacterium tuberculosis drug resistance, Madagascar, 2005-2006
    Ramarokoto, H.
    Ratsirahonana, O.
    Soares, J. L.
    Ravaosolo, J.
    Ravololonandriana, P.
    Rakotoarisaonina, A.
    Ranjalahy, G.
    Ranaivohajaina, S.
    Mosa, M.
    Robinson, R.
    Ratsitorahina, M.
    Rasolofo, V.
    Rarivoson, B.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2010, 14 (06) : 745 - 750
  • [22] Association between Mycobacterium tuberculosis Complex Phylogenetic Lineage and Acquired Drug Resistance
    Yuen, Courtney M.
    Kurbatova, Ekaterina V.
    Click, Eleanor S.
    Cavanaugh, J. Sean
    Cegielski, J. Peter
    PLOS ONE, 2013, 8 (12):
  • [23] Association between embB codon 306 mutations and drug resistance in Mycobacterium tuberculosis
    Shen, Xin
    Shen, Guo-miao
    Wu, Jie
    Gui, Xiao-hong
    Li, Xia
    Mei, Jian
    DeRiemer, Kathryn
    Gao, Qian
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (07) : 2618 - 2620
  • [24] Association of streptomycin resistance mutations with level of drug resistance and Mycobacterium tuberculosis genotypes
    Nhu, N. T. Q.
    Lan, N. T. N.
    Phuong, N. T. N.
    Chau, N. van V.
    Farrar, J.
    Caws, M.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2012, 16 (04) : 527 - 531
  • [25] The GenoType® MTBDRplus assay for detection of drug resistance in Mycobacterium tuberculosis in Sweden
    Chryssanthou, Erja
    Angeby, Kristiana
    APMIS, 2012, 120 (05) : 405 - 409
  • [26] Evolution of drug resistance in different sublineages of Mycobacterium tuberculosis Beijing genotype
    Mokrousov, Igor
    Wei Wei Jiao
    Gui Zhi Sun
    Jia Wen Liu
    Valcheva, Violeta
    Li, Mo
    Narvskaya, Olga
    Shen, A. Dong
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (08) : 2820 - 2823
  • [27] Mycobacterium tuberculosis Beijing Genotype in Western Iran: Distribution and Drug Resistance
    Mohajeri, Parviz
    Moradi, Sakineh
    Atashi, Sara
    Farahani, Abbas
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2016, 10 (10) : DC5 - DC7
  • [28] Survey of primary drug resistance of Mycobacterium tuberculosis in Casablanca, Morocco
    ElBaghdadi, J
    Lazraq, R
    Ibrahimy, S
    Bouayad, Z
    Guinet, R
    Benslimane, A
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 1997, 1 (04) : 309 - 313
  • [29] Drug Resistance Profiles of Mycobacterium tuberculosis Complex and Factors Associated with Drug Resistance in the Northwest and Southwest Regions of Cameroon
    Meriki, Henry D.
    Tufon, Kukwah A.
    Atanga, Pascal N.
    Ane-Anyangwe, Irene N.
    Anong, Damian N.
    Cho-Ngwa, Fidelis
    Nkuo-Akenji, Theresa
    PLOS ONE, 2013, 8 (10):
  • [30] Molecular Characteristics and Drug Resistance of Mycobacterium tuberculosis Isolate Circulating in Shaanxi Province, Northwestern China
    Yang, Jian
    Zhang, Tianhua
    Xian, Xiaoping
    Li, Yan
    Wang, Rui
    Wang, Panting
    Zhang, Meng
    Wang, Junyang
    MICROBIAL DRUG RESISTANCE, 2021, 27 (09) : 1207 - 1217